Table 1.
ALL N = 86 | Dead N = 24 | Alive N = 62 | p | |
---|---|---|---|---|
Age | 10.7 (2.93) | 9.58 (3.59) | 11.1 (2.55) | 0.068 |
Sex | 0.831 | |||
Male | 54 (62.8%) | 16 (66.7%) | 38 (61.3%) | |
Female | 32 (37.2%) | 8 (33.3%) | 24 (38.7%) | |
Region | 1.000 | |||
Urban | 44 (51.2%) | 12 (50.0%) | 32 (51.6%) | |
Rural | 42 (48.8%) | 12 (50.0%) | 30 (48.4%) | |
Medical.insurance | 0.392 | |||
No | 42 (48.8%) | 14 (58.3%) | 28 (45.2%) | |
Yes | 44 (51.2%) | 10 (41.7%) | 34 (54.8%) | |
Primary.site | 0.179 | |||
Limb | 80 (93.0%) | 24 (100%) | 56 (90.3%) | |
Axial | 6 (6.98%) | 0 (0.00%) | 6 (9.68%) | |
lateral | 0.057 | |||
Left | 46 (53.5%) | 10 (41.7%) | 36 (58.1%) | |
Right | 34 (39.5%) | 14 (58.3%) | 20 (32.3%) | |
Not pairs | 6 (6.98%) | 0 (0.00%) | 6 (9.68%) | |
Stage | <0.001 | |||
I | 28 (32.6%) | 2 (8.33%) | 26 (41.9%) | |
II | 24 (27.9%) | 2 (8.33%) | 22 (35.5%) | |
III | 21 (24.4%) | 9 (37.5%) | 12 (19.4%) | |
IV | 13 (15.1%) | 11 (45.8%) | 2 (3.23%) | |
Surgery | 0.310 | |||
Limb salvage | 82 (95.3%) | 22 (91.7%) | 60 (96.8%) | |
Amputation | 4 (4.65%) | 2 (8.33%) | 2 (3.23%) | |
Chemotherapy | 0.496 | |||
No | 12 (14.0%) | 2 (8.33%) | 10 (16.1%) | |
Yes | 74 (86.0%) | 22 (91.7%) | 52 (83.9%) | |
Radiotherapy | 0.573 | |||
No | 82 (95.3%) | 24 (100%) | 58 (93.5%) | |
Yes | 4 (4.65%) | 0 (0.00%) | 4 (6.45%) | |
Size | 71.0 (37.4) | 89.9 (28.6) | 63.7 (38.0) | 0.001 |
PLR | 128 (73.6) | 166 (86.8) | 113 (62.6) | 0.011 |
NLR | 1.61 (0.72) | 1.90 (0.73) | 1.49 (0.69) | 0.021 |
SII | 677 (464) | 913 (462) | 586 (436) | 0.005 |
Platelet | 407 (157) | 474 (146) | 381 (154) | 0.013 |
Neutrophile | 5.14 (1.48) | 5.66 (1.24) | 4.94 (1.53) | 0.026 |
Lymphocyte | 3.56 (1.17) | 3.35 (1.43) | 3.65 (1.06) | 0.367 |
Metastasis | 1.000 | |||
No | 78 (90.7%) | 22 (91.7%) | 56 (90.3%) | |
Yes | 8 (9.30%) | 2 (8.33%) | 6 (9.68%) | |
Survival. months | 33.6 (23.4) | 21.2 (21.9) | 38.4 (22.3) | 0.002 |